Radioactive injection targets advanced neuroendocrine tumors in new trial
NCT ID NCT06398444
Summary
This study is testing whether a radioactive drug injection can safely control advanced neuroendocrine cancer that has progressed despite other treatments. The trial involves 74 adults with inoperable, spreading tumors that have specific markers. Participants receive the injection every 8 weeks while doctors monitor tumor response and side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED NEUROENDOCRINE NEOPLASM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, China
Conditions
Explore the condition pages connected to this study.